LifeMD, Inc. (LFMDP) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
236 FIFTH AVENUE NEW YORK, NY 10001 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8011 - Offices and Clinics of Doctors of Medicine (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 35,005 | 33,147 | 3,959 | 41,328 | 9,179 | 1,107 | |||
| Cash and cash equivalent | 35,005 | 33,147 | 3,959 | 41,328 | 9,179 | 1,107 | |||
| Receivables | 8,218 | 5,277 | 2,835 | 980 | 648 | 97 | |||
| Inventory, net of allowances, customer advances and progress billings | 2,797 | 2,760 | 3,703 | 1,617 | 1,264 | 950 | |||
| Inventory | 2,797 | 2,760 | 3,703 | 1,617 | 1,264 | 950 | |||
| Deposits current assets | 41 | 486 | 127 | 204 | 817 | ||||
| Other current assets | 2,672 | 935 | 687 | 793 | 155 | 443 | |||
| Other undisclosed current assets | 150 | ||||||||
| Total current assets: | 48,733 | 42,604 | 11,311 | 44,921 | 12,063 | 2,747 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 6,401 | 595 | 1,206 | 1,752 | 274 | 24 | |||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 1,479 | 476 | 476 | 234 | |||||
| Intangible asset, including goodwill, after accumulated amortization | 2,031 | 3,009 | 3,832 | 20 | 340 | 675 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 2,031 | 3,009 | 3,832 | 20 | 340 | 675 | |||
| Other undisclosed noncurrent assets | 13,817 | 11,796 | 8,840 | 2,996 | 376 | ||||
| Total noncurrent assets: | 23,727 | 15,876 | 14,354 | 5,002 | 990 | 699 | |||
| TOTAL ASSETS: | 72,460 | 58,481 | 25,666 | 49,923 | 13,054 | 3,446 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 36,821 | 25,022 | 22,273 | 20,655 | 11,794 | 3,051 | |||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 2,000 | ||||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 1,658 | ||||
| Accounts payable | 16,009 | 11,085 | 10,107 | 9,059 | |||||
| Accrued liabilities | 20,812 | 13,937 | 12,167 | 7,066 | |||||
| Other undisclosed accounts payable and accrued liabilities | 871 | 11,794 | 3,051 | ||||||
| Deferred revenue | 14,481 | 8,829 | 5,500 | 110 | |||||
| Debt | 8,444 | 328 | 2,797 | 63 | 779 | 815 | |||
| Other undisclosed current liabilities | 509 | 603 | 804 | 2,107 | 917 | ||||
| Total current liabilities: | 60,255 | 34,782 | 31,374 | 22,826 | 13,490 | 3,975 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 9,885 | 17,928 | 1,179 | ||||||
| Long-term debt, excluding current maturities | 9,885 | 17,928 | |||||||
| Liabilities, other than long-term debt | 6,365 | 205 | 1,018 | 100 | |||||
| Operating lease, liability | 6,265 | 74 | 574 | 1,179 | |||||
| Business combination, contingent consideration, liability | 100 | 131 | 444 | 100 | |||||
| Other undisclosed noncurrent liabilities | 579 | 385 | 600 | ||||||
| Total noncurrent liabilities: | 16,250 | 18,133 | 1,597 | 1,279 | 385 | 600 | |||
| Total liabilities: | 76,505 | 52,915 | 32,971 | 24,104 | 13,875 | 4,575 | |||
| Commitments and contingencies | 500 | ||||||||
| Temporary equity, including noncontrolling interest | 4,566 | 4,111 | 3,656 | (500) | |||||
| Equity | |||||||||
| Equity, attributable to parent | (5,486) | 3,505 | (11,396) | 22,740 | (2,302) | (988) | |||
| Preferred stock | 0 | 0 | 0 | 0 | |||||
| Common stock | 423 | 384 | 316 | 307 | 234 | 534 | |||
| Treasury stock, value | (164) | (164) | (164) | (164) | (164) | (164) | |||
| Additional paid in capital | 230,508 | 217,551 | 179,015 | 164,518 | 77,779 | 15,236 | |||
| Accumulated deficit | (236,253) | (214,265) | (190,563) | (141,921) | (80,152) | (16,595) | |||
| Equity, attributable to noncontrolling interest | 1,440 | 2,061 | (476) | (1,032) | (2,176) | (141) | |||
| Total equity: | (4,045) | 5,566 | (11,871) | 21,708 | (4,478) | (1,129) | |||
| TOTAL LIABILITIES AND EQUITY: | 72,460 | 58,481 | 25,666 | 49,923 | 13,054 | 3,446 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 212,454 | 152,547 | 119,034 | 92,876 | 37,294 | 12,469 | ||
| Cost of revenue | (24,068) | (18,900) | (18,668) | (17,995) | (8,907) | (3,271) | ||
| Gross profit: | 188,385 | 133,647 | 100,365 | 74,880 | 28,386 | 9,198 | ||
| Operating expenses | (204,530) | (148,136) | (143,813) | (129,181) | (86,206) | (12,088) | ||
| Operating loss: | (16,145) | (14,489) | (43,448) | (54,301) | (57,819) | (2,890) | ||
| Nonoperating expense | (2,582) | |||||||
| Interest and debt expense | (2,922) | (1,276) | (7,015) | (915) | (761) | |||
| Loss from continuing operations before equity method investments, income taxes: | (16,145) | (17,411) | (44,724) | (61,316) | (61,317) | (3,651) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (2,182) | 63 | 915 | |||||
| Loss from continuing operations before income taxes: | (18,326) | (17,411) | (44,660) | (61,316) | (60,402) | (3,651) | ||
| Income tax expense (benefit) | (402) | (428) | (361) | (8) | (123) | 123 | ||
| Loss from continuing operations: | (18,728) | (17,839) | (45,021) | (61,324) | (60,524) | (3,528) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (61,324) | (60,524) | (3,528) | |
| Income from discontinued operations | ||||||||
| Net income (loss): | (18,728) | (17,839) | (45,021) | (61,324) | (60,524) | (3,528) | ||
| Net income (loss) attributable to noncontrolling interest | (153) | (2,757) | (515) | 426 | 1,877 | 391 | ||
| Net income (loss) attributable to parent: | (18,882) | (20,596) | (45,536) | (60,898) | (58,647) | (3,137) | ||
| Preferred stock dividends and other adjustments | (3,106) | (3,106) | (3,106) | (871) | (4,716) | |||
| Net income (loss) available to common stockholders, diluted: | (21,988) | (23,702) | (48,642) | (61,769) | (63,363) | (3,137) | ||
Comprehensive Income ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (18,728) | (17,839) | (45,021) | (61,324) | (60,524) | (3,528) | ||
| Comprehensive income (loss): | (18,728) | (17,839) | (45,021) | (61,324) | (60,524) | (3,528) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (153) | (2,757) | (515) | 426 | 1,877 | 391 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (18,882) | (20,596) | (45,536) | (60,898) | (58,647) | (3,137) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.